Health News Archive - January 19, 2009
FDA has not completed routine investigator site and CRO vendor inspections OSAKA, Japan, Jan.
Now in its 25th year, company positions itself for continued leadership in cellular and molecular immunology and allergy testing for clinical diagnostics, life-science research, and pharmaceutical development LENEXA, Kan., Jan.
MONT-SAINT-GUIBERT, Belgium, January 19 /PRNewswire/ -- - New Funds to Drive Clinical Development of C-Cure(R), a Second-Generation Cell-Based Therapy for Heart Failure Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, has raised EUR7.2 million in a successful Series B fund raising round.
BOSTON, Jan. 19 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) will release Second Quarter Fiscal Year 2009 financial results on Monday, January 26, 2009 after the close of the stock market.
This Milestone Signifies The Company's Commitment to Healthy and Successful Vascular Access for Kidney Patients VERNON HILLS, Ill., Jan.
Frost & Sullivan to Host Quarterly Analyst Briefing on the European Medical Imaging market on Wednesday 28 January 2009 LONDON, Jan.
Successful Deployments in U.S. and Abroad Reported WALL, N.J., Jan. 19 /PRNewswire-FirstCall/ -- BIO-key International, Inc.
SAN DIEGO, Jan. 19 /PRNewswire/ - Canada's six genome centres demonstrated the power of partnerships by hosting their 2nd Annual Canadian Genomics Reception at the International Plant and Animal Genomics Conference in San Diego last week.
Innovation in design fuels The Amazing Heat Pack by Comfort Now, Inc., a revolutionary first aid product that provides affordable and renewable instant pain relief for athletes, arthritics, chronic pain sufferers, premenstrual women and anyone else suffering from painful joints and muscles BURLINGTON, Ontario, Jan.
- A terrible or repulsive person.